PATH malaria vaccine modelling

The malaria vaccine RTS,S is currently in Phase 4 studies and undergoing pilot implementation in 3 countries in Africa.  Supporting ongoing policy decisions by Gavi and MPAC/SAGE on RTS,S, model based estimates are required to take into account possible scenarios with other malaria interventions when assessing the potential public health impact and cost effectiveness of a vaccine to be introduced in malaria endemic African countries. The aim of this grant is to provide these model based estimates and to further evaluate the introduction, dynamics of the vaccine, and the distributional impacts via new model development and analysis of clinical data.

Public Health

Contact

Melissa Penny

Melissa Penny, SNF Professor, PhD, PD
Deputy Head of Unit, Group Leader

+41 61 284 8701
melissa.pennyswisstph.ch

Project Facts